Related Subjects:
|Chronic liver disease
|Cirrhosis
|Alkaline phosphatase (ALP)
|Liver Function Tests
|Ascites Assessment and Management
|Budd-Chiari syndrome
|Autoimmune Hepatitis
|Primary Biliary Cirrhosis
|Primary Sclerosing Cholangitis
|Wilson disease
|Hereditary Haemochromatosis
|Alpha-1 Antitrypsin (AAT) deficiency
|Non alcoholic steatohepatitis (NASH)
|Spontaneous Bacterial Peritonitis
|Alcoholism and Alcoholic Liver Disease
β οΈ These are not true βliver function testsβ but rather markers of liver damage or cholestasis.
π Normal LFTs β normal liver.
π¨ The three main causes of severe derangement of all enzymes are:
Hepatic ischaemia, Viral hepatitis, and Drugs/Toxins.
π§ͺ Key Liver Blood Tests
- π΄ AST (Aspartate Aminotransferase) β Raised in liver injury (esp. alcohol-related) but not liver-specific. Also elevated in heart and muscle disease.
- π ALT (Alanine Aminotransferase) β More specific to hepatocyte injury (e.g. viral hepatitis, NAFLD).
- π‘ ALP (Alkaline Phosphatase) β Marker of cholestasis or obstruction. Also made in bone & placenta β‘οΈ check GGT to confirm hepatic origin.
- π’ GGT (Gamma-Glutamyl Transferase) β Rises with ALP in biliary disease. Sensitive to alcohol and drugs (phenytoin, barbiturates).
- π Bilirubin β Breakdown product of haem.
β Conjugated β β obstruction, hepatocellular disease
β Unconjugated β β haemolysis, Gilbertβs syndrome.
- π Albumin β Low in chronic liver disease (ascites, oedema). Also reduced in nephrotic syndrome, sepsis, malnutrition.
- π©Έ PT/INR β Prolonged if liver fails to make clotting factors. Important in paracetamol overdose & acute liver failure. Always give Vit K to exclude deficiency.
- π£ Platelets β Low in cirrhosis due to splenomegaly & portal hypertension.
- 𧬠AFP (Alpha-Fetoprotein) β Tumour marker for hepatocellular carcinoma (HCC).
- βοΈ Ammonia β Raised in hepatic encephalopathy (toxic accumulation).
- π Liver Biopsy β Gold standard for diagnosis & staging fibrosis (can be via jugular if coagulopathy).
- π‘ FibroScan β Non-invasive measure of stiffness (fibrosis/cirrhosis).
- πΌοΈ Imaging (USS, CT, MRI) β Liver size, morphology, masses, biliary tree, ascites, vascular flow.
π Focused History for Abnormal LFTs
- π Medications β recent antibiotics, herbal remedies, paracetamol use.
- π Travel β rural/countryside, water sports (e.g. leptospirosis).
- π IV or recreational drug use (Hep B/C risk).
- πΊ Alcohol intake β CAGE questions, history of withdrawal (DTs).
- β€οΈ Sexual history & transfusions pre-1990 (HIV, Hepatitis risk).
- π€ Associated symptoms β fever, rigors, vomiting, pale stools, dark urine, pruritus, weight loss, abdo pain.
- π Features of chronic liver disease β ascites, encephalopathy, coagulopathy, jaundice.
π¨ Causes of Liver Injury
- π¦ Viral hepatitis (AβE, CMV, EBV, HSV).
- πΊ Alcohol-related liver disease.
- π Drug-induced hepatotoxicity (paracetamol, statins, anti-TB meds).
- π Ischaemic hepatitis (βshock liverβ).
- π’ Obstructive jaundice (stones, tumours, PSC/PBC).
- βοΈ NAFLD with T2DM (AST > ALT pattern).
π§Ύ Interpretation of Specific Tests
- π©Έ PT/INR β Reflects liver synthetic function. Raised in paracetamol OD, fulminant failure. Always try Vit K β persistent abnormality = true liver dysfunction.
- π Albumin β Falls in cirrhosis, but also sepsis, nephrotic syndrome, malnutrition.
- π§ Urea β Often low in liver disease (reduced metabolism). High in GI bleed (protein load).
- βοΈ Ammonia β Linked to encephalopathy, esp. fulminant liver failure.
- π‘ Bilirubin β Conjugated β = obstruction; Unconjugated β = haemolysis, Gilbertβs.
- π‘ ALP β Canalicular enzyme, cholestasis. Cross-check with GGT.
- π AST/ALT β
β AST:ALT > 2 β Alcoholic liver disease πΊ
β ALT more specific to liver π§‘
β Mild β (<100): chronic hepatitis, fatty liver
β Moderate β (100β300): autoimmune hepatitis, NASH, Wilsonβs
β Marked β (>300): paracetamol OD, viral hepatitis, ischaemia.
π§ͺ Further Investigations (βLiver Screenβ)
- π¦ Viral serology β HBsAg, HCV Ab, HAV IgM, HSV, CMV, HIV, Β± Hepatitis D IgM.
- 𧬠Autoimmune markers β ANA, ASMA, AMA, immunoglobulins.
- βοΈ Metabolic β Ferritin, transferrin saturation, caeruloplasmin & copper (if <55), A1AT phenotype.
- π©Έ AFP β screen for HCC.
- π©Ί Imaging β USS (structure, obstruction, PV patency), MRCP/ERCP if obstructive pattern.
- π Biopsy β histology & fibrosis staging.
- π¨ NAC early if any suspicion of paracetamol overdose.